In turn, Lee et al. [137] showed that benzyl-d(U)TP-modified DNA aptamer that was directed against human POSTN selectively bound to FAS-1 domain (PNDA-3) of POSTN inhibited breast cancer growth and metastasis in vivo. The gene discussed is POSTN; the disease is breast carcinoma.